An Indiana family is demanding accountability from the U.S. Food and Drug Administration (FDA) after their 9-year-old son, Colton George, nearly died from a severe E. coli infection that caused his kidneys to fail.
On January 16, 2025, U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas, ruled that Idaho, Missouri, and Kansas can continue their lawsuit against the U.S. Food and Drug Administration (FDA) seeking to restrict the availability of the abortion pill mifepristone.
In the final days of President Joe Biden’s administration, federal officials unveiled a proposal to reduce nicotine levels in cigarettes, a move aimed at curbing addiction and reducing smoking rates. The Food and Drug Administration (FDA) has been working on this initiative for years, marking a significant step in tobacco regulation.
The Food and Drug Administration (FDA) announced that it will ban Red No. 3 in food, drinks, and pharmaceutical products. Red No. 3 is a synthetic coloring frequently used in candies, desserts, and some drugs.
Elon Musk announced that Neuralink, his brain-computer interface (BCI) company, has successfully implanted its experimental device in a third human subject. The announcement, made...
Respiratory Syncytial Virus (RSV) vaccines from GSK and Pfizer will carry warnings for an increased risk of Guillain-Barré syndrome (GBS), the U.S. Food Drug Administration (FDA) said.
The FDA is advancing a controversial regulation to lower nicotine levels in cigarettes, drawing criticism for potential unintended consequences, including fueling black market activity.
A team of high school students from Centreville High School in Virginia, collaborating with the FDA, has uncovered concerning levels of DNA contamination in Pfizer’s experimental and commercial mRNA COVID-19 vaccines.
Costco has issued a recall for a Kirkland Signature cold and flu medicine due to potential contamination with foreign materials. The recall involves Kirkland Signature Severe Cold & Flu Plus Congestion, item number #1729556, with lot code P140082.
